TPST Annual Total Long Term Liabilities
$15.42 M
-$5.28 M-25.49%
31 December 2023
Summary:
As of January 20, 2025, TPST annual total long term liabilities is $15.42 million, with the most recent change of -$5.28 million (-25.49%) on December 31, 2023. During the last 3 years, it has fallen by -$73.01 million (-82.56%). TPST annual total long term liabilities is now -82.56% below its all-time high of $88.43 million, reached on December 31, 2020.TPST Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Quarterly Long Term Liabilities
$8.41 M
-$2.27 M-21.23%
30 September 2024
Summary:
As of January 20, 2025, TPST quarterly total long term liabilities is $8.41 million, with the most recent change of -$2.27 million (-21.23%) on September 30, 2024. Over the past year, it has dropped by -$9.35 million (-52.66%). TPST quarterly long term liabilities is now -90.49% below its all-time high of $88.43 million, reached on December 31, 2020.TPST Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.5% | -52.7% |
| 3 y3 years | -82.6% | -52.7% |
| 5 y5 years | -82.6% | -52.7% |
TPST Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.5% | at low | -59.4% | at low |
| 5 y | 5-year | -82.6% | at low | -90.5% | at low |
| alltime | all time | -82.6% | at low | -90.5% | at low |
Tempest Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.41 M(-21.2%) |
| June 2024 | - | $10.67 M(-18.3%) |
| Mar 2024 | - | $13.05 M(-15.4%) |
| Dec 2023 | $15.42 M(-25.5%) | $15.42 M(-13.1%) |
| Sept 2023 | - | $17.75 M(+3.9%) |
| June 2023 | - | $17.09 M(-9.3%) |
| Mar 2023 | - | $18.85 M(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $20.70 M(+21.1%) | $20.70 M(+67.8%) |
| Sept 2022 | - | $12.34 M(-11.8%) |
| June 2022 | - | $14.00 M(-16.6%) |
| Mar 2022 | - | $16.78 M(-1.8%) |
| Dec 2021 | $17.09 M(-80.7%) | $17.09 M(-1.8%) |
| Sept 2021 | - | $17.40 M(-1.1%) |
| June 2021 | - | $17.59 M(-80.1%) |
| Dec 2020 | $88.43 M | $88.43 M |
FAQ
- What is Tempest Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Tempest Therapeutics?
- What is Tempest Therapeutics annual total long term liabilities year-on-year change?
- What is Tempest Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly long term liabilities year-on-year change?
What is Tempest Therapeutics annual total long term liabilities?
The current annual total long term liabilities of TPST is $15.42 M
What is the all time high annual total long term liabilities for Tempest Therapeutics?
Tempest Therapeutics all-time high annual total long term liabilities is $88.43 M
What is Tempest Therapeutics annual total long term liabilities year-on-year change?
Over the past year, TPST annual total long term liabilities has changed by -$5.28 M (-25.49%)
What is Tempest Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TPST is $8.41 M
What is the all time high quarterly long term liabilities for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly total long term liabilities is $88.43 M
What is Tempest Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TPST quarterly total long term liabilities has changed by -$9.35 M (-52.66%)